HEADER GLYCOPROTEIN/AMYLOID PEPTIDE 08-OCT-02 1O6N OBSLTE 21-APR-05 1O6N 2BP4 TITLE (1-16) FRAGMENT OF THE BETA-AMYLOID PROTEIN (BETA-APP40, TITLE 2 BETA-APP42) IN TFE/WATER 80/20 SOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALZHEIMER'S DISEASE AMYLOID A4 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 672-687; COMPND 5 SYNONYM: PROTEASE NEXIN-II, PN-II, APPI, BETA-AMYLOID COMPND 6 PROTEIN, BETA-APP, A-BETA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS ALZHEIMER'S DISEASE, AMYLOID PEPTIDE, BETA-AMYLOID PROTEIN EXPDTA NMR, 30 STRUCTURES AUTHOR S.ZIRAH,A.BLOND,M.CHEMINANT,S.KOZIN,I.SEGALAS-MILAZZO, AUTHOR 2 P.DEBEY,S.REBUFFAT REVDAT 2 21-APR-05 1O6N 1 OBSLTE REVDAT 1 07-NOV-02 1O6N 0 JRNL AUTH S.ZIRAH,S.A.KOZIN,A.BLOND,M.CHEMINANT,P.DEBEY, JRNL AUTH 2 S.REBUFFAT JRNL TITL ROLE OF THE 1-16 N-TERMINAL REGION IN THE JRNL TITL 2 TRANSCONFORMATION INVOLVED IN ALZHEIMER'S DISEASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR3.1 REMARK 3 AUTHORS : BRUNGER NUMBER OF NON-HYDROGEN ATOMS USED IN REMARK 3 REFINEMENT. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: INPUT DATA USED FOR STRUCTURE REMARK 3 CALCULATION CONSIST IN 162 UPPER AND LOWER DISTANCE RESTRAINTS REMARK 3 AND 9 AMBIGUOUS RESTRAINTSFROM NOE DATA (NOESY 100MS) AND 11 REMARK 3 PHI DIHEDRAL ANGLE RESTRAINTS REMARK 4 REMARK 4 1O6N COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY EBI ON 9-OCT-2002. REMARK 100 THE EBI ID CODE IS EBI-11499. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : COSY-DQF, TOCSY, NOESY, HSQC, REMARK 210 HMBC REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ, 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE400, DMX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : BRUKER X-WIN NMR NMR, BRUKER REMARK 210 AURELIA AURELIA, X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION, REMARK 210 ALLOWED REGIONS IN REMARK 210 RAMACHANDRAN PLOT REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 8 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 400 REMARK 400 COMPOUND MAJOR COMPONENT OF EXTRACELLULAR AMYLOID PLAQUES REMARK 400 AND VASCULAR AMYLOID DEPOSITS CHARACTERISTIC OF BOTH REMARK 400 ALZHEIMER'S DISEASE (AD) AND AGED DOWN'S SYNDROME. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 15 125.80 75.14 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AAP RELATED DB: PDB REMARK 900 RELATED ID: 1AMB RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE REMARK 900 (RESIDUES 1 - 28) (NMR, MINIMIZED AVERAGE STRUCTURE) REMARK 900 RELATED ID: 1AMC RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE REMARK 900 (RESIDUES 1 - 28) (NMR, 5 STRUCTURES) REMARK 900 RELATED ID: 1AML RELATED DB: PDB REMARK 900 THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE REMARK 900 (RESIDUES 1-40) REMARK 900 RELATED ID: 1BA4 RELATED DB: PDB REMARK 900 THE SOLUTION STRUCTURE OF AMYLOID BETA- REMARK 900 PEPTIDE (1-40) IN A WATER-MICELLE REMARK 900 ENVIRONMENT. IS THE MEMBRANE-SPANNING DOMAIN REMARK 900 WHERE WE THINK IT IS? NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1BA6 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED REMARK 900 AMYLOID BETA-PEPTIDE (1-40). DOES REMARK 900 OXIDATION AFFECT CONFORMATIONAL SWITCHING? REMARK 900 NMR,10 STRUCTURES REMARK 900 RELATED ID: 1BJB RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], REMARK 900 RESIDUES 1-28, 14 STRUCTURES REMARK 900 RELATED ID: 1BJC RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16], REMARK 900 RESIDUES 1-28, 15 STRUCTURES REMARK 900 RELATED ID: 1BRC RELATED DB: PDB REMARK 900 RELATED ID: 1CA0 RELATED DB: PDB REMARK 900 BOVINE CHYMOTRYPSIN COMPLEXED TO APPI REMARK 900 RELATED ID: 1MWP RELATED DB: PDB REMARK 900 N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR ROTEIN REMARK 900 RELATED ID: 1QCM RELATED DB: PDB REMARK 900 AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1TAW RELATED DB: PDB REMARK 900 BOVINE TRYPSIN COMPLEXED TO APPI DBREF 1O6N A 1 16 UNP P05067 A4_HUMAN 672 687 SEQRES 1 A 16 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 16 HIS GLN LYS HELIX 1 1 ALA A 2 ASP A 7 1 6 HELIX 2 2 ASP A 7 HIS A 13 1 7 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1